Skip to main content
. 2019 Dec 27;11:359–367. doi: 10.2147/RRU.S233386

Figure 1.

Figure 1

Alpha- and beta-diversity measurements for the groups in this study. No significant differences were observed in alpha-diversity measurements between never and ever smokers (A) nor patients with or without bladder cancer (B). No significant differences were observed in weighted UniFrac beta-diversity measurement between never and ever smokers (C) nor patients with or without bladder cancer (D).